MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
$82,229K
Free Cash flow
-$16,623K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from the issuance of co...
Share-based compensation expense
Trade and other payables
Others
Negative Cash Flow Breakdown
Share and warrant issuance trans...
Prepaid and other assets
Lease liabilities
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2026-06-30
2025-06-30
Unrealized loss on investment
-
0
Net loss
-45,546
-37,917
Depreciation and amortization
58
66
Amortization of right-of-use assets
423
330
Gain on extinguishment of liabilities
0
764
Share-based compensation expense
26,410
17,426
Trade and other receivables
-30
-197
Prepaid and other assets
948
111
Trade and other payables
3,272
-2,378
Accrued employee benefits
126
-81
Lease liabilities
-343
-356
Net cash used in operating activities
-16,518
-23,588
Purchase of property and equipment
105
18
Net cash used in investing activities
-105
-18
Proceeds from issuance of common stock, pre-funded warrants, and common warrants
-
30,460
Proceeds from the issuance of common stock
104,495
-
Proceeds from exercise of pre-funded warrants, series 2 warrants and common warrants
748
42,344
Share and warrant issuance transaction costs
6,266
2,319
Net cash provided by financing activities
98,977
70,485
Effects of exchange rate changes on cash, cash equivalents, and restricted cash
-125
49
Net increase in cash, cash equivalents, and restricted cash
82,229
46,928
Cash, cash equivalents, and restricted cash, beginning of period
97,857
50,929
Cash, cash equivalents, and restricted cash, end of period
180,086
97,857
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
BNTC Cash Flow Sankey Diagram
Sankey diagram visualizing BNTC cash flow for the period
Proceeds from the
issuance of common stock
$104,495K
Proceeds from exercise of
pre-funded warrants,...
$748K
(-98.23%↓ Y/Y)
Net cash provided by
financing activities
$98,977K
(40.42%↑ Y/Y)
Canceled cashflow
$6,266K
Net increase in
cash, cash...
$82,229K
(75.22%↑ Y/Y)
Canceled cashflow
$16,748K
Share and warrant
issuance transaction...
$6,266K
(170.20%↑ Y/Y)
Share-based compensation
expense
$26,410K
(51.56%↑ Y/Y)
Trade and other
payables
$3,272K
(237.59%↑ Y/Y)
Amortization of right-of-use
assets
$423K
(28.18%↑ Y/Y)
Accrued employee
benefits
$126K
(255.56%↑ Y/Y)
Depreciation and
amortization
$58K
(-12.12%↓ Y/Y)
Trade and other
receivables
-$30K
(84.77%↑ Y/Y)
Net cash used in
operating activities
-$16,518K
(29.97%↑ Y/Y)
Effects of exchange rate
changes on cash, cash...
-$125K
(-355.10%↓ Y/Y)
Net cash used in
investing activities
-$105K
(-483.33%↓ Y/Y)
Canceled cashflow
$30,319K
Net loss
-$45,546K
(-20.12%↓ Y/Y)
Purchase of property and
equipment
$105K
(483.33%↑ Y/Y)
Prepaid and other assets
$948K
(754.05%↑ Y/Y)
Lease liabilities
-$343K
(3.65%↑ Y/Y)
Buy us a coffee
Benitec Biopharma Inc. (BNTC)
Benitec Biopharma Inc. (BNTC)